Agreement signing
The Ministry of Industry and Mineral Resources and King Abdullah International Medical Research Center (KAIMRC) signed a memorandum of understanding (MoU) with Pfizer to set a basis for the local manufacturing of viral and genetic vaccines in the Kingdom.
Under the MoU, Pfizer will also provide the technical support required for building a platform for human cells.
The preliminary deal was signed today, Sept. 14, at the Riyadh Global Medical Biotechnology Summit 2021 (RGMBS). Separately, AstraZeneca inked an MoU with the Ministry of Investment and the Ministry of National Guard - Health Affairs (MNG-HA).
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}